XASXCNB
Market cap46mUSD
Jan 09, Last price
0.35AUD
1D
1.45%
1Q
-7.89%
IPO
34.62%
Name
Carnaby Resources Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
21.22%
Rev. gr., 5y
-6.94%
Revenues
0k
Net income
-12m
L-1.21%
CFO
-12m
L+6.85%
Earnings
Feb 12, 2025
Profile
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records. The company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. It serves customers through channel partners. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. Beamtree Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | 101 | 12,780 | 9,771 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (101) | (12,780) | (9,771) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | 822 | 3 | (2) | ||||||
Tax Rate | |||||||||
NOPAT | (923) | (12,780) | (9,771) | ||||||
Net income | (12,086) -1.21% | (12,234) 48.89% | (8,216) -2,312.41% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (7) | 18,649 | 18,743 | ||||||
BB yield | 0.01% | -12.03% | -16.12% | ||||||
| Debt | |||||||||
Debt current | 47 | 19 | 46 | ||||||
Long-term debt | 84 | 19 | 37 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | 496 | 375 | 357 | ||||||
Net debt | (10,658) | (27,265) | (18,227) | ||||||
| Cash flow | |||||||||
Cash from operating activities | (12,045) | (11,273) | (8,162) | ||||||
CAPEX | (4,411) | (190) | (1,137) | ||||||
Cash from investing activities | (3,506) | 586 | (370) | ||||||
Cash from financing activities | (173) | 19,680 | 19,802 | ||||||
FCF | (958) | (12,780) | (9,944) | ||||||
| Balance | |||||||||
Cash | 10,312 | 26,941 | 17,947 | ||||||
Long term investments | 478 | 362 | 362 | ||||||
Excess cash | 10,789 | 27,303 | 18,309 | ||||||
Stockholders' equity | 26,777 | 31,608 | 23,526 | ||||||
Invested Capital | 16,549 | 4,699 | 5,638 | ||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 163,974 | 147,609 | 129,176 | ||||||
Price | 0.48 -54.29% | 1.05 16.67% | 0.90 160.87% | ||||||
Market cap | 78,707 -49.22% | 154,990 33.31% | 116,259 179.73% | ||||||
EV | 68,049 | 127,724 | 98,032 | ||||||
EBITDA | (101) | (12,686) | (9,720) | ||||||
EV/EBITDA | |||||||||
Interest | 7 | 9 | 8 | ||||||
Interest/NOPBT | |||||||||